RE: investbest7 Apr 2020 21:54
ValiRx
London, UK, 1 April 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces:
-- that it has conditionally raised GBP200,000 of gross proceeds through the issue of 5,714,288* new ordinary shares (post reorganisation) at a post reorganisation price of 3.5 pence* per share ("Placing Shares") with new investors ("Conditional Placing"). The Conditional Placing is conditional, inter alia, of the passing of resolution 1 (share capital reorganisation) as set out in the circular posted to shareholders dated 6 March 2020 convening a meeting on 25 March 2020 ("Capital Reorganisation General Meeting"). The Capital Reorganisation General Meeting was adjourned on 25 March 2020;
-- the appointment of Peterhouse Capital Limited ("Peterhouse") as sole broker to the Company; and
-- the proposed appointment of Martin Lampshire as a Non-executive Director.